High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial

Published:2015-08 Issue:8 Volume:25 Page:1167-1177
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Müller Christian A.,Geisel Olga,Pelz Patricia,Higl Verena,Krüger Josephine,Stickel Anna,Beck Anne,Wernecke Klaus-Dieter,Hellweg Rainer,Heinz Andreas

Funder

German Research Foundation (Cluster of Excellence EXC 257 NeuroCure)

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference51 articles.

1. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatric Association (APA),2000

2. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study;Addolorato;Alcohol Alcohol,2002

3. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial;Addolorato;Alcohol Alcohol,2011

4. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study;Addolorato;Lancet,2007

5. GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence;Agabio;Front. Neurosci.,2014

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging GPCR targets for AUD: Insights from preclinical studies;Current Opinion in Neurobiology;2024-08

2. Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder;Expert Opinion on Emerging Drugs;2024-04-18

3. Medication-induced central sleep apnea: a unifying concept;SLEEP;2024-02-09

4. Baclofen in the treatment of alcohol use disorder: tailored doses matter;Alcohol and Alcoholism;2024-01-17

5. Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta‐analysis;Addiction;2024-01-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3